Mia Bendix

Randers, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease.

Increased mucosal and T-cell expression of 4-1BB and PD-1 are modulated by anti-TNFα treatment in Crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: May 24, 2025

Gal-3 blocks the binding between PD-1 and pembrolizumab.

Gal-3 blocks the binding between PD-1 and pembrolizumab.

Journal: Journal for immunotherapy of cancer

Published: September 20, 2024

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: June 07, 2024

Fecal Supernatants from Patients with Crohn's Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts.

Fecal Supernatants from Patients with Crohn's Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts.

Journal: Cells

Published: November 22, 2023

Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-Up.

Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn's Disease during One-Year Follow-Up.

Journal: Nutrients

Published: March 04, 2021

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.

Journal: Nutrients

Published: November 05, 2020

Current, experimental, and future treatments in inflammatory bowel disease: a clinical review.

Current, experimental, and future treatments in inflammatory bowel disease: a clinical review.

Journal: Immunopharmacology and immunotoxicology

Published: May 11, 2018

High-dose vitamin D3 supplementation decreases the number of colonic CD103+ dendritic cells in healthy subjects.

High-dose vitamin D3 supplementation decreases the number of colonic CD103+ dendritic cells in healthy subjects.

Journal: European journal of nutrition

Published: December 20, 2016

Vitamin D increases programmed death receptor-1 expression in Crohn's disease.

Vitamin D increases programmed death receptor-1 expression in Crohn's disease.

Journal: Oncotarget

Published: November 18, 2016

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.

Journal: Mediators of inflammation

Published: September 23, 2015

Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study.

Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study.

Journal: European journal of clinical investigation

Published: September 15, 2015

Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.

Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.

Journal: Clinical and experimental immunology

Published: October 28, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026